...
首页> 外文期刊>Transplant international : >The impact of changing practice on improved outcomes of paediatric renal transplantation in the United Kingdom: a 25 years review
【24h】

The impact of changing practice on improved outcomes of paediatric renal transplantation in the United Kingdom: a 25 years review

机译:改变实践对英国儿科肾移植改善成果的影响:25年的审查

获取原文
获取原文并翻译 | 示例
           

摘要

Summary This review reports the outcomes of paediatric renal transplantation in the United Kingdom over the last 25 years. UK Transplant Registry data on 3236 paediatric renal transplants performed between 1 January 1992 and 31 December 2016 were analysed. Significant improvements in human leucocyte antigen ( HLA ) matching have been achieved; 84% of recipients received 000 or favourable (0 DR and 0 or 1 B) mismatched kidneys in 2016 compared with 27% in 1992. The median waiting time has increased from 126 days in 1999 to 351 days in 2016. Tacrolimus replaced ciclosporin in most immunosuppressive regimens after 2002. Renal transplant outcome has improved significantly, mainly because of a reduction in early graft loss. One‐year donation after brain death renal allograft survival for those transplanted from 2012 to 2016 was 98%, compared with 72% for those transplanted from 1987 to 1991. Renal allograft survival for first kidney only transplants at 1, 5, 10, 20 and 25 years were 89%, 79%, 65%, 42% and 33% respectively. Superior survival with living donor was maintained throughout the study period with 25‐year graft survival at 33% compared with 31% from deceased donor ( P 0.0001). Changes in immunosuppression regimens, improvements in HLA matching and a reduction of cold ischaemia time may in part explain the improvements in graft survival.
机译:简介审查在过去25年中报告了英国儿科肾移植的结果。在1992年1月1日至2016年12月31日之间进行的3236个儿科肾移植的英国移植登记数据进行了分析。已经实现了人白细胞抗原(HLA)匹配的显着改善; 2016年,84%的受助人接受了000或有利的(0博士和0或1 b)不匹配的肾比值,而1992年相比27%。等候时间从1999年的126天增加到2016年的351天。Tacromus最多地取代了Ciclosporin 2002年后免疫抑制方案。肾移植结果显着提高,主要是由于早期接枝损失的降低。从2012年到2016年移植的人脑死肾同种异体移植物生存率的一年捐款为98%,而1987年至1991年移植的人相比,72%。肾同种异体移植物存活的第一个肾脏仅在1,5,10,20及其移植25岁分别为89%,79%,65%,42%和33%。在整个研究期间维持与生活捐赠的优越生存,在33%以25年的移植物存活率为33%,而死者供体的31%(P <0.0001)。免疫抑制方案的变化,HLA匹配的改善和冷缺血时间的减少可以分别解释移植物存活的改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号